SYK
Stryker Corporation (S&P 500)
Healthcare — Medical Devices
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Price History
Fundamentals
| Market Cap | $132.87B |
| P/E Ratio (TTM) | 40.07 |
| Forward P/E | 20.72 |
| EPS (TTM) | $8.65 |
| Dividend Yield | 1.05% |
| Profit Margin | 13.21% |
| Revenue Growth | 2.60% |
| ROE | 15.20% |
| Debt/Equity | 66.30 |
| Recommendation | Buy 1.6 |
| Analyst Target | $387.04 |
| Analysts | 26 |
| Indexes | S&P 500 |
Technical Indicators
| RSI (14) | 59.5 |
| Beta | 0.78 |
| SMA 20 | $323.93 |
| SMA 40 | $316.26 |
| 52-Week High | $403.92 |
| 52-Week Low | $281.00 |
| 50-Day Avg | $314.61 |
| 200-Day Avg | $343.69 |
| Avg Volume | $2.79M |
| Volume | $2.52M |
Performance Analysis
BULLISHSYK shows predominantly bullish signals based on its fundamentals and technicals.
Recent News
Last updated: Jul 28, 2026 21:01 UTC
Back to Screener Export Report